DUBLIN, Nov. 3, 2022 (GLOBE NEWSWIRE) — The “HMO market by type (2′ Fl, 3′ Fl, 3′ Sl, 6′ Sl), application (infant formula, functional foods and beverages, dietary supplements), concentration (acidic, neutral), and region (North America, Europe, APAC , South America, RoW) – Global Forecast to 2027” Report has been added ResearchAndMarkets.com Offer.
The global market for HMO is estimated at USD 199 million in 2022. It is projected to reach USD 556 million by 2027, registering a CAGR of 22.7% over the forecast period.
The Asia-Pacific region is forecast to grow by 23.2% over the forecast period
Asia-Pacific accounts for $92.6 million of the market size in the global HMO market. The region is expected to grow at the highest CAGR over the forecast period and maintain its dominance as the leading market for HMOs. The Asia Pacific is the most densely populated region made up of countries like China, India, Japan, Australia and New Zealand among others. It is also one of the key markets for HMOs.
China is a dominant market in the region as it is one of the largest consumers of infant formula in the world. Therefore, any market fluctuation in China is expected to significantly affect the global infant formula market, which in turn will have an impact on the HMO market. China is projected to be the largest human milk oligosaccharides (HMO) market in 2022.
The country has seen a high acceptance of infant formulas made from quality ingredients including…
